Pre-existing autoimmune disease as a risk factor for immune-related adverse events in cancer patients receiving immune checkpoint inhibitors
Hidetoshi Sumimoto(Shiga University of Medical Science), Yataro Daigo(The University of Tokyo), Satoshi Noda(Shiga University of Medical Science Hospital), Kosuke Sakai(University of Occupational and Environmental Health Japan), Akihito Nishikawa(Shiga University of Medical Science), Hiroyoshi Koide(Shiga University of Medical Science Hospital), Koji Teramoto(Shiga University of Medical Science), Yuri Kimura(Hiroshima University), Hiromi Nakato(Shiga University of Medical Science), Yutaro Douke(Shiga University of Medical Science Hospital), Satoshi Murata(Shiga University of Medical Science), Maki Hori(Shiga University of Medical Science), Atsushi Takano(The University of Tokyo), Azumi Tomioka(Shiga University of Medical Science), Aya Tokuda(Shiga University of Medical Science)
Cited by 16
Related Papers
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
HJURP Is a Cell-Cycle-Dependent Maintenance and Deposition Factor of CENP-A at Centromeres
|Cell|2009|636
Mutations truncating the EP300 acetylase in human cancers
|Nature Genetics|2000|593
Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases
|Nature Genetics|2020|591
Genome-wide association study of hematological and biochemical traits in a Japanese population
|Nature Genetics|2010|535